Endostatin is protective against monocrotaline-induced right heart disease through the inhibition of T-type Ca2+ channel
Endostatin is protective against monocrotaline-induced right heart disease through the inhibition of T-type Ca2+ channel
复制标题
DOI:
10.1007/s00424-016-1810-0
复制
发表时间:
2016-07-01
影响因子:
4.5
通讯作者:
Yamawaki, Hideyuki
中科院分区:
文献类型:
--
作者:
Imoto, Keisuke;Kumatani, Sayaka;Yamawaki, Hideyuki
Endostatin (ES), a C-terminal fragment of collagen XVIII alpha 1, has a potent anti-angiogenic effect. ES prevents tumor proliferation through inhibiting T-type Ca2+ channel. T-type Ca2+ channel is re-expressed during heart diseases including monocrotaline (MCT)-induced right heart failure. The present study aimed to clarify the effects of ES on T-type Ca2+ channel and pathogenesis of MCT-induced right ventricular disease. MCT or saline was injected intraperitoneally to rats. After cardiomyocytes were isolated from right ventricles (RVs), T-type Ca2+ channel current (I (CaT)) was measured by a patch-clamp method. After ES small interfering RNA (siRNA) or control siRNA (20 mu g) was administrated for 1 week via the right jugular vein 1 week after MCT injection, echocardiography and histological analysis were done. I (CaT) was significantly increased in RV from MCT-injected rats, and ES significantly inhibited it. The survival rate of ES siRNA-administrated MCT rats (MCT ES si group) was decreased. In echocardiography, although ES siRNA did not affect pulmonary arterial pressure, RV systolic function was impaired in MCT ES si group compared with control siRNA-administrated MCT rats (MCT cont si group). In the histological analysis of RV, ES expression was increased in MCT cont si group, and ES siRNA inhibited it. Furthermore, although MCT cont si group showed only cardiomyocyte hypertrophy, MCT ES si group showed notable enlargement of intercellular spaces. The present study for the first time revealed that ES inhibits T-type Ca2+ channel activity in RV from MCT-injected rats. ES gene knockdown deteriorates MCT-induced right heart disease. ES is thus cardioprotective possibly through inhibiting T-type Ca2+ channel activity.